Parasitic worm infections – or helminthiases – affect more than one billion people and have a considerable public health impact in many parts of the world. On 7 – 8 December 2017, international experts will gather in Basel, Switzerland, to discuss new strategies to control and eliminate parasitic worms. The scientific symposium is hosted by the Swiss Tropical and Public Health Institute.
Approximately 1.5 billion people globally are affected by soil-transmitted helminthiasis and another 250 million suffer from schistosomiasis; two of the most common parasitic worm infections. They are transmitted by different species of parasitic worms in the soil or water and can result in diarrhoea, malnutrition, impaired growth and enlargement of the liver or spleen. The morbidity caused by chronic helminth infections can debilitate entire communities and contribute to poverty in endemic areas.
160 scientists gather in Basel
To review current strategies and to discuss new ways of preventing, controlling and eliminating helminth infections, the Swiss Tropical and Public Health Institute (Swiss TPH) is hosting a two-day symposium in Basel, Switzerland.
Over 160 scientists and experts are on hand to critically review innovations in diagnostics and drugs and to discuss control strategies to interrupt transmission of parasitic worm infections. One presentation will show results from Zanzibar that demonstrate how a multifaceted intervention package can reduce prevalence of infection among school-aged children to less than 2%.
“Although parasitic worms affect one out of five people worldwide, they belong to the so-called neglected tropical diseases, which are intimately linked to poverty,” says Jürg Utzinger, Director of Swiss TPH. “While we see certain progress, we need to further foster innovation, refine existing tools and strategies and employ integrated control approaches that are tailored to social-ecological contexts.”
“New drugs urgently needed”
Innovations are urgently needed in drug discovery and development. “Our research indicates that efficacy of current anthelminthic drugs is declining,” says Jennifer Keiser, Head of the Helminth Drug Development Unit at Swiss TPH and recently appointed Associate Professor of Neglected Tropical Diseases at the University of Basel. “Hence, there is a pressing need to discover and develop new drugs and rigorously evaluate potential combination therapies. This symposium is a terrific opportunity for Swiss TPH to showcase our existing partnerships and to develop new collaborations.”
Leading institute in tackling helminthiases
Swiss TPH is one of the world’s leading institutions for researching and developing new treatments, conducting clinical trials and implementing control and elimination initiatives in the area of parasitic worm infection. Swiss TPH partners with local, national and international organisations, such as the Pediatric Praziquantel Consortium, the Tribendimidine Consortium and the Tomsk Opisthorchiasis Consortium. Swiss TPH also hosts the WHO Collaborating Centre for Epidemiology and Control of Helminth Infections.
About Swiss TPH
The Swiss Tropical and Public Health Institute is a world-leading institute in global health with a particular focus on low- and middle-income countries. Associated with the University of Basel, Swiss TPH combines research, services, and education and training at the local, national and international level. Over 800 people from more than 70 nations work at Swiss TPH focusing on infectious and non-communicable diseases, environment, society and health as well as health systems and interventions. www.swisstph.ch
More on parasitic worm infections at Swiss TPH: www.swisstph.ch/helminths
More on the Swiss TPH Winter Symposium: https://www.swisstph.ch/en/about/events/winter-symposium-2017
Programme Winter Symposium: https://www.swisstph.ch/fileadmin/user_upload/SwissTPH/Events/Symposia/WS2017/Pr...
Anna Wegelin | idw - Informationsdienst Wissenschaft
Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"
13.04.2018 | Max-Planck-Institut für molekulare Genetik
Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018
12.04.2018 | Forschungsverbund Berlin e.V.
At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.
Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...
Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.
Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
24.04.2018 | Information Technology
24.04.2018 | Earth Sciences
24.04.2018 | Life Sciences